structur
polypeptid
nmrine
coronaviru
vim
diarrhoea
viru
infant
mice
analys
comparison
strain
jhm
mhv
sdspage
presenc
three
major
glyeopolypeptid
gp
group
similar
speci
one
major
nonglycosyl
polypeptid
p
detect
gp
dvim
specif
glyeopolypeptid
glycosid
moieti
link
core
polypeptid
nglycosid
bond
henc
may
correl
short
project
viral
envelop
fulther
appear
absenc
reduc
agent
appar
dimer
gp
held
togeth
disulfid
linkag
gp
famili
hand
consist
four
polypeptid
two
axe
metabol
inhibit
tunicamyein
suggest
olink
glycopolypeptid
dvim
seem
serolog
close
relat
mhv
strain
shown
neutrmiz
coronavirus
group
envelop
virus
contain
larg
singlestrand
rna
genom
messeng
polar
howev
murin
coronavirus
distinguish
coronavirus
presenc
olink
oligosaccharid
previou
studi
morpholog
biolog
activ
murin
eoronaviru
strain
dvim
diarrhoea
viru
infant
mice
reveal
presenc
characterist
short
project
locat
base
clubshap
eoronaradi
dvim
virion
therefor
interest
studi
structur
polypeptid
viru
especi
comparison
well
character
murin
coronavirus
report
describ
characterist
major
glycopolypeptid
gp
exclus
detect
dvim
probabl
correspond
short
project
also
describ
effect
tunicamycin
synthesi
variou
structur
polypeptid
degre
immunocross
reactiv
dvim
protein
mous
enter
coronaviru
dvim
adapt
growth
dbt
cell
use
eagl
mem
supplement
per
cent
calf
serum
per
cent
tryptos
phosphat
broth
difco
lab
viru
clone
three
consecut
plaqu
passag
addit
mous
hepat
viru
strain
jhm
miv
obtain
hom
r
k
fujiwara
univers
tokyo
tokyo
japan
dbt
cell
cultur
suspenmon
respect
also
clone
purifi
similar
procedur
describ
previous
virus
moi
allow
adsorb
confluent
monolay
dbt
cell
minut
c
follow
cell
wash
twice
dulbecco
pb
fed
supplement
per
cent
dimys
calf
serum
methionin
concentr
mem
reduc
onetenth
normal
medium
four
hour
infect
medium
replac
methioninefre
mem
contain
per
cent
dialys
calf
serultt
vciml
cimmol
amersham
corp
vim
also
label
mcimmol
amersham
corp
mannos
cimrnol
icn
radio
cheml
cat
ahlfueos
cimmom
amersham
corp
ciml
procedur
without
reduct
methionin
respect
experi
viru
adsorpt
tunicamycin
sigma
chem
co
ad
final
concentr
xgml
experi
virion
harvest
hour
infect
purifi
describ
sampl
analys
per
cent
slab
gel
method
lae
mli
protein
treat
sampl
buffer
boil
minut
separ
slab
gel
hour
gel
prepar
fluorographi
expos
kodak
xomat
r
film
c
iyperimmun
sera
purifi
virion
strain
prepar
rabbit
describ
previous
viru
neutral
viru
incub
fourfold
dilut
antiserum
hour
c
final
volum
ml
incub
mixtur
transfer
monolay
bt
cell
micropl
use
four
replica
per
virusserum
dilut
test
score
cytopatholog
hour
c
immunoprecipit
purifi
label
virion
disrupt
per
cent
nte
edta
pit
buffer
disrupt
viral
compon
incub
antiserum
minut
c
mix
l
per
cent
formalinfix
solut
aureu
mile
sei
dissolv
nte
buffer
incub
minut
c
immunocomplex
bound
aureu
wash
four
time
nte
contain
per
cent
tritonx
eentrifug
final
pellet
suspend
sampl
buffer
contain
boil
minut
aureu
deposit
low
speed
eentrifug
supernat
load
gel
immunolog
relationship
dvim
well
character
strain
murin
coronavirus
examin
crossneutr
tabl
dvim
found
close
relat
hmv
strain
addit
bilater
minor
crossreact
dvim
also
observ
contrast
dvim
show
weak
crossreact
jitm
strong
unilater
crossreact
also
detect
dvim
serum
result
therefor
show
gener
dvii
serologi
relat
strain
murin
coronavirus
particularli
mhv
approxim
molecular
weight
virion
polypeptid
determin
compar
etectrophoret
mobil
commerci
avail
standard
biorad
per
cent
polyacrylamid
tube
gel
accord
procedur
maizl
dvim
four
major
polypeptid
molecular
weight
respect
one
minor
polypeptid
molecular
weight
detect
smallest
major
polypeptid
speci
produc
broad
band
group
three
four
close
migrat
band
page
profil
dvim
gener
similar
observ
marin
coronavirus
except
one
major
band
moh
wt
detect
divm
virion
exclus
mhv
strain
also
polypeptid
moh
wt
similar
dvim
lacglueosamin
label
dvimwa
use
identifi
glycosyl
peptid
analys
reveal
three
major
polypeptid
moh
wt
glycosyl
henc
design
gp
respect
wherea
major
polypeptid
mol
wt
glyeosyl
design
fig
b
interest
label
wherea
famili
polypeptid
label
addit
dvim
specif
gp
label
find
therefor
indic
variou
dvim
glyeopolypeptid
differ
accord
composit
sugar
residu
moieti
presenc
disulfid
bond
structur
polypeptid
studi
sdspage
analysi
assmethionin
label
dvim
absenc
compar
mhv
condit
gp
dvim
could
longer
detect
instead
new
speci
polypeptid
mot
wt
observ
fig
c
suggest
polypeptid
disulfidelink
dimer
two
smaller
glycopolypeptid
gp
mitv
also
similar
disulfidelink
oligomeri
speci
order
studi
serolog
crossreact
dvin
polypeptid
mhv
strain
label
fig
thu
use
homolog
antisera
structur
polypeptid
dvim
precipit
minor
band
migrat
slightli
faster
speci
detect
immunopreeipit
assum
degrad
product
probabl
nucleoeapsid
protein
hand
immunoreact
heterolog
antisera
indic
wherea
strong
crossreact
dvim
faint
crossreact
gp
gp
respect
seem
howev
show
consider
crossreact
antimhv
serum
contrast
dvim
specif
polypeptid
immunologi
relat
glycoprotein
murin
coronavirus
shown
fig
lmost
strainspecif
polypeptid
immunoreact
antii
vim
serum
vari
degre
indic
structur
protein
dvim
except
gp
immunolog
relat
mhv
strain
identifi
type
glycosid
bond
present
structur
glyeoprotein
dvim
infect
dbt
cell
treat
tunicamycin
gml
describ
earlier
viral
particl
isol
tunicamycin
treat
cell
lack
infect
haemagglutin
activ
data
shown
viral
particl
analys
togeth
virus
nontreat
cell
sdspolyacrylamid
gel
reduc
condit
fig
iesult
indic
gp
dvimspecif
glycopolypeptid
gp
could
longer
detect
follow
tunicamycin
treatment
cell
addit
appear
consist
four
polypeptid
w
x
z
small
glycopolypeptid
also
disappear
complet
contrast
synthesi
w
x
affect
z
partial
affect
drug
result
togeth
abil
mannos
incorpor
polypeptid
fig
b
indic
b
virion
control
discuss
glycopeptid
gp
appear
equival
largest
glycoprotein
present
wellcharacter
mous
hepat
virus
think
peplomeri
protein
accord
find
investig
although
minor
glycopolypeptid
weakli
detect
gel
also
assum
peplomeri
protein
henc
probabl
associ
gp
b
noneoval
bond
gp
hand
detect
exclus
dvim
virion
major
structur
polypeptid
remov
larg
project
dvim
proteolyt
digest
result
loss
gp
intact
dvim
virion
howev
viral
particl
still
retain
haemagglutin
activ
correl
presenc
gp
data
shown
therefor
suggest
close
relationship
small
granular
project
viral
haemagglutin
activ
therefor
specul
structur
compon
small
granular
project
locat
close
envelop
presum
fig
c
subunit
larger
glyeoprotein
gp
bound
disulfid
linkag
oligomeri
structur
interestingli
similar
disulfid
link
glyeopolypeptid
describ
porcin
haemagglutin
encephalomyel
viru
bovin
coronaviru
suggest
polypeptid
may
repres
haemagglutinin
gener
therefor
haemagglutin
coronavirus
may
share
oligomer
protein
distinct
structur
featur
form
small
granular
project
studi
also
reveal
unaffect
proteas
treatment
data
shown
henc
appar
protect
viral
envelop
suggest
locat
intern
henc
consid
nueleoprotein
propos
worker
studi
found
famili
protein
slightli
affect
proteas
treatment
henc
inclin
assum
embed
within
viral
envelop
shown
fig
famili
glyeoprotein
consist
four
polypeptid
speci
design
w
x
z
gel
polypeptid
gave
band
correspond
report
rottir
et
al
compar
band
respect
synthesi
w
x
affect
tunieamycin
treatment
suggest
carbohydr
side
chain
protein
may
link
polypeptid
oglycosid
bond
fact
evid
exist
type
bond
vim
indic
sensit
alkali
treatment
elimin
condit
data
shown
contrast
synthesi
protein
well
gp
complet
inhibit
tunieamycin
treatment
howev
fail
detect
ahmannos
follow
label
characterist
nglyeosid
bond
glycoprotein
famili
therefor
present
defin
type
glycosid
bond
protein
work
support
part
naito
foundat
grant
